Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Myomo (MYO), CVS Health (CVS) and Insulet (PODD) with bullish sentiments.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Myomo (MYO)
Alliance Global Partners analyst Scott Henry maintained a Buy rating on Myomo today and set a price target of $3.00. The company’s shares closed last Wednesday at $1.06.
According to TipRanks.com, Henry is ranked 0 out of 5 stars with an average return of
Myomo has an analyst consensus of Strong Buy, with a price target consensus of $5.25.
See the top stocks recommended by analysts >>
CVS Health (CVS)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health today and set a price target of $125.00. The company’s shares closed last Wednesday at $99.12.
According to TipRanks.com, CFA is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CVS Health with a $112.81 average price target, which is a 20.4% upside from current levels. In a report released yesterday, TipRanks – PerPlexity also upgraded the stock to Buy with a $115.00 price target.
Insulet (PODD)
In a report released today, Daniel Markowitz CFA from Evercore ISI maintained a Buy rating on Insulet, with a price target of $180.00. The company’s shares closed last Wednesday at $133.26.
According to TipRanks.com, CFA is a 4-star analyst with an average return of
Insulet has an analyst consensus of Moderate Buy, with a price target consensus of $183.05, representing a 43.0% upside. In a report issued on July 31, TipRanks – OpenAI also upgraded the stock to Buy with a $189.00 price target.
Read More on MYO:
